Global Hospital Acquired Disease Testing Market, by Test Type (Urinary Tract Infection, Surgical Site Infection, Pneumonia, Blood Stream Infection, Methicillin-resistant Staphylococcus Aureus, and others) and by Region - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

  • Published On : Oct 2017 |
  • Pages : 140 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Hospital acquired Disease Testing – Hospital or Mortuary

Hospital acquired disease or nosocomial infection is a localized or systemic condition in patients occurred due to adverse reaction caused by infectious toxin agents under medical care and were absent at the time of admission. Hospitals acquired infections results in prolonged hospital stay, antimicrobial resistance, long-term disabilities, and increase mortality rate. Pathogens responsible for nosocomial infections include viruses, fungal parasites, and bacteria.

Hospital acquired infection is emerging as a major burden for society, patients, and healthcare management

Hospital acquired disease could be catheter-related blood stream infection, surgical site infection, ventilator-associated pneumonia, and catheter-associated urinary tract infection. These infection occurring in emerging economies globally. According Asia Pacific Journal of Tropical Medicine, 2017, Nosocomial infections account for around 10% in emerging economies and around 7% in developed economies out of all the infections. According to the World Health Organization (WHO), 2011, approximately around 15% patients hospitalized suffer from above mentioned infections, due to exposure to pathogens through different sources, such as healthcare staff and infected patients. Newborns, especially in emerging economies are also at high risk to develop hospital acquired infection. According to WHO, 2011, the infection rate in newborns is 20 times higher in emerging economies as compared to high income economies.

Hospital acquired infection is emerging as a major burden for society, patients, and healthcare management. Nosocomial infections could be prevented by practicing infection control programs and adopting antimicrobial control policies. For instance, National Health & Medical Research Council Australia (NHMRC), 2002 provided critical guidelines for the management of infections, prevention, and control in healthcare organizations.

The global hospital acquired disease testing market was valued at US$ 539 million in 2016 and is expected to witness a robust CAGR of 19.70% over the forecast period (2017 - 2025).

Global Hospital Acquired Disease Testing Market, by Region, 2016 (US$ Mn)

hospital acquired disease testing

Source: Coherent Market Insights 2017

Antibodies resistance and extended hospitalization is expected to propel growth of hospital acquired disease testing in the near future

High prevalence of nosocomial infections such as surgical wounds, urinary tract infections, and lower respiratory tract infections in intensive care units, orthopedic, and acute surgical ward fuels growth of hospital acquired disease testing market. The technique used for preventions, diagnosis, and testing of hospital acquired diseases are microarray, PCR, and solid phase hybridization. The urinary tract infections is most common in patients dwelling with urinary catheter, as urethra is located close to the anus, which increases the changes of invasions of bacteria from large intestine into the urinary tracts. Therefore, expenses and antibiotic resistance increases with extended hospitalization, which in turn propels growth of hospital acquired disease testing market.

Factors such as favorable government initiatives towards nosocomial infections, regulatory guidelines and reimbursement scenario are expected to boost the hospital acquired disease testing market in North America and Europe. For instance, medicare and private insurance companies are eliminating the reimbursement rate due to high rate of hospital acquired infection (HAI) incidence during 2014-2015, adding economic pressures on hospitals to reduce hospital acquired diseases. However, unhygienic conditions and practices in developing and underdeveloped regions is resulting in higher incidences of HAI in these regions. Thus, there is urgent requirement for HAI testing in these regions during the forecast period.

The key market players are Diatherix laboratories, Life technologies, Cantel Medical Corporation Meridian Biosciences, Qiagen GmbH, Nordion, Roche, and Cepheid & others.

Hospital-acquired diseases are those infections that are acquired by the patient under medical care. The most common type of hospital-acquired infections are urinary tract infection, bloodstream infections, MRSA, pneumococcal infections, and gastrointestinal illnesses. An increasing rate of morbidity related to hospital-acquired infections worldwide is the major driver for the growth of hospital-acquired disease testing market. Devices employed in modern care facilities, such as catheters and ventilators are also associated with the cause of these infections.

Market Dynamics

According to World health organization (WHO), 2011, highest prevalence of hospital-acquired infections occur in intensive care units, orthopedic, and acute surgical ward. According to an article in Journal of Nursing & Health Sciences, 2016, the prevalence rate of hospital-acquired diseases is approximately 5.1% to 11.6% in emerging economies. Around 1.7 million people are affected by HAI in the U.S. itself accounting for 9.9 infections per 1000 patients a day. High prevalence rate is the key factor propelling the growth of market in near future.

Urinary tract infection is the most common infection, owing to its high risk in the patients indwelling with urinary catheter, which leads to increase chance of bacterial invasion from the anus to the urinary tract and promotes colonization of bacteria.

The most common techniques used for diagnosis of the hospital-associated infections are solid phase hybridization, PCR, and microarrays. Curetis Unyvero System, launched in 2012, a new molecular device used for rapid detection microorganism and antibiotic resistance gene. Antibiotic resistance is also the major concern factor associated with hospital-acquired Disease testing.

Key features of the study:

  • This report provides an in-depth analysis of global hospital-acquired disease testing market, provides market size (US$ 539 Million), and Cumulative Annual Growth Rate (19.70 %) for the forecast period (2017 – 2025), considering 2016 as the base year.
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.
  • It profiles leading players in the global hospital-acquired disease testing market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
  • Key companies covered as a part of this study include Diatherix laboratories, Life technologies, Cantel Medical Corporation Meridian Biosciences, Qiagen GmbH, Nordion, and Roche Cepheid.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
  • The global hospital-acquired disease testing market report caters to various stakeholders in this industry including investors, suppliers, hospital-acquired disease testing manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the hospital acquired disease testing and consumables market.

Detailed Segmentation:

  • Global Hospital-acquired Disease Testing market, By Test Type :
    • Urinary Tract Infection
    • Surgical Site Infection
    • Pneumonia Stents
    • Blood Stream Infection
    • Methicillin-resistant Staphylococcus Aureus
    • Others
  • Global Hospital-acquired Disease Testing market, By Geography:
    • North America
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus
        • Others
      • By Country
        • U.S.
        • Canada
    • Europe
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus
        • Others
      • By Country
        • U.K.
        • Germany
        • Italy
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus
        • Others
      • By Country
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus
        • Others
      • By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus
        • Others
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus
        • Others
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Diatherix laboratories*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Life technologies
    • Cantel Medical Corporation
    • Meridian Biosciences
    • Nordion
    • Qiagen GmbH
    • Roche
    • Cepheid

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Test Type
      • Market Snippet By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Regulatory Scenario
    • Industry Trend
    • Merger and Acquisitions
    • Epidemiology
    • Preventive Initiatives
  4. Global Hospital Acquired Disease Testing Market, By Test type, 2015 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, 2015 - 2025
      • Segment Trends
    • Urinary Tract Infection
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Surgical Site Infection
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Pneumonia
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Blood Stream Infection
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  5. Global Hospital Acquired Disease Testing Market, By Regions, 2015 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2015 – 2025
      • Regional Trends
    • North America
      • Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  6. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Diatherix laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Life technologies
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Cantel Medical Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Meridian Biosciences
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Nordion
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Qiagen GmbH
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Roche
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Cepheid
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  7. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 33 market data tables and 30 figures on "Hospital Acquired Disease Testing Market” - Global forecast to 2025”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.